img
Evaluation of Patients with COVID-19 Followed Up in Intensive Care Units in the Second Year of the Pandemic: A Multicenter Point Prevalence Study      
Yazarlar
Sinem Güngör
Türkiye
Özlem Ediboğlu
Türkiye
Özlem Yazıcıoğlu Moçin
Türkiye
Nalan Adıgüzel
Türkiye
Eylem Tunçay
Türkiye
İnşa Gül Ekiz İşcanlı
Türkiye
Berrin Er
Türkiye
Zühal Karakurt
Türkiye
Behiye Deniz Kosovalı
Türkiye
Nevzat Mehmet Mutlu
Türkiye
Duygu Kayar Çalılı
Ankara Yıldırım Beyazıt Üniversitesi, Türkiye
Şerife Gökbulut Bektaş
Türkiye
Elmas Uysal
Türkiye
Deniz Erdem
Türkiye
Nazan Has Selmi
Türkiye
Pınar Güven
Türkiye
Zerrin Özçelik
Türkiye
Halil Cebeci
Türkiye
Bahar Güler
Türkiye
İlker Solmaz
Türkiye
Fatma Özkan Sipahioğlu
Türkiye
Eda Macit Aydın
Türkiye
Hakan Dayanır
Türkiye
Serkan Özen
Türkiye
Maruf Boran
Türkiye
Dursun Fırat Ergül
Türkiye
Umut Sabri Kasapoğlu
Türkiye
Leman Acun Delen
Türkiye
Erol Toy
Türkiye
Koray Altun
Türkiye
Tuna Albayrak
Türkiye
Hülya Yanal
Türkiye
Gökhan Kılınç
Türkiye
Doç. Dr. Veysel Garani SOYLU Doç. Dr. Veysel Garani SOYLU
Türkiye
Saba Mukaddes Saygılı
Türkiye
Pınar Ayvat
İzmir Demokrasi Üniversitesi, Türkiye
Özet
OBJECTIVE: A 1-day point prevalence study was planned to obtain country data by determining the clinical characteristics, follow-up and treatment methods of coronavirus disease 2019 (COVID-19) cases that required intensive care unit (ICU) treatment in the second year of the pandemic. MATERIAL AND METHODS: All patients who were hospitalized in the ICUs due to COVID-19 between March 11, 2022, 08.00 am, and March 12, 2022, 08.00 am, were included in the study. Demographic characteristics, intensive care and laboratory data, radiological characteristics, and follow-up results of the patients were recorded. RESULTS: A total of 811 patients from 59 centers were included in the study, 59% of the cases were male, and the mean age was 74 ± 14 years. At least one comorbid disease was present in 94% of the cases, and hypertension was the most common. When ICU weight scores were examined, Acute Physiology and Chronic Health Evaluation-II: 19 (15-27) and Sequential Organ Failure Assessment: 7 (4-10) were seen. Sepsis was present in 37% (n = 298) of cases. PaO2 /FiO2 ratios of the patients were 190 the highest and 150 the lowest and 51% of the cases were followed via invasive mechanical ventilation. On the study day, 73% bilateral involvement was seen on chest x-ray, and ground-glass opacities (52%) were the most common on chest tomography. There was growth in culture in 40% (n = 318) of the cases, and the most common growth was in the tracheal aspirate (42%). CONCLUSION: The clinical course of COVID-19 is variable, and ICU follow-up was required due to advanced age, comorbidity, presence of respiratory symptoms, and widespread radiological involvement. The need for respiratory support and the presence of secondary infection are important issues to be considered in the follow-up. Despite the end of the second year of the pandemic and vaccination, the high severity of the disease as well as the need for follow-up in ICUs has shown that COVID-19 is an important health problem.
Anahtar Kelimeler
COVID-19 | follow-up | intensive care | intensive care unit | pandemic
Makale Türü Özgün Makale
Makale Alt Türü ESCI dergilerinde yayımlanan tam makale
Dergi Adı Thoracic Research and Practice
Dergi ISSN 2979-9139
Dergi Tarandığı Indeksler ESCI
Makale Dili İngilizce
Basım Tarihi 11-2024
Cilt No 25
Sayı 1
Sayfalar 11 / 16
Doi Numarası 10.5152/ThoracResPract.2023.23024
Makale Linki http://dx.doi.org/10.5152/thoracrespract.2023.23024